Intellectual Property UK

  • August 20, 2026

    Advanz Looks To Nix Regeneron, Bayer Eye Med Patents

    Pharmaceutical company Advanz has asked a London court to revoke a number of U.K. eye medicine patents belonging to Regeneron and Bayer, arguing that the treatments are not inventive enough.

  • August 20, 2026

    Security Co. Appeals Loss To Chinese Drone Maker At UPC

    A Dutch security company has doubled down on its patent infringement claim against a Chinese drone manufacturer in Europe, appealing against the Unified Patent Court's decision to throw out its case.

  • August 20, 2026

    Real Betis FC Can't Give 'Betty' TM The Boot

    Real Betis FC has failed to persuade European officials to block the owner of a womenswear label from registering the trademark "Betty," finding little risk that fans would mistake it for the Spanish football club.

  • August 20, 2026

    Novartis Sees Eye Syringe Patent Fail In Europe

    A European appeals panel has refused to revive Novartis' patent for a syringe that delivers eye medicine, ruling that the company's blueprint for the device extends beyond the contents of its original patent filings.

  • August 19, 2026

    Biggest UK And EU Patent Developments Of 2026 So Far

    For patent owners, the first half of 2026 brought few answers to mounting questions, but several key rulings signify increasing pressures in the artificial intelligence and telecommunications space that threaten to disrupt the status quo for U.K. and European patent litigation.

  • August 19, 2026

    Maintenance Co. Sues Ex-Director Over Client Poaching

    A facilities management business has sued a former director for allegedly sharing sensitive financial information with a rival in an effort to steer major clients away from the company.

  • August 19, 2026

    Takeda Faces Joint Attack On Entyvio Patents In April

    A London judge has told Takeda that it must defend its patents for bowel disease drug Entyvio during a single trial in April, combining attacks against its protections from four different generic drugmakers.

  • August 19, 2026

    UK Research Agency Sues Ex-Consultant Over Data Theft

    The government's research and development agency has sued a former consultant for allegedly downloading tens of thousands of files, including confidential material, on to his personal device.

  • August 18, 2026

    InHealth Sues Radiologists For Using IP To Launch Rival

    A U.K. provider of diagnostics services has accused a group of radiologists of stealing thousands of confidential documents, allowing them to set up a rival company and take one of its clients.

  • August 18, 2026

    Fintech Directors Shifted IP Worth £2M To Defraud Creditors

    A London judge held Tuesday that two former directors of a financial software business defrauded creditors by transferring intellectual property rights worth £2 million ($2.7 million) amid an impending threat of insolvency.

  • August 18, 2026

    Sibionics Loses 2nd Bid At Nixing Abbott Patent

    Europe's patent court has granted Abbott Diabetes exclusive rights over a glucose monitoring device that can be fitted in a single step, rejecting claims from a Sibionics unit that earlier devices already revealed its key features. 

  • August 18, 2026

    Disney Seeks To Undo UPC Ban Over Video Streaming Tech

    Disney has brought two appeals against InterDigital as the U.S. entertainment giant looks to overturn a Unified Patent Court injunction restricting its use of a video-coding patent across its streaming platforms.

  • August 18, 2026

    Publishers Can't Take Control Of Iraq War Video Game

    A London court has denied a request by the publishers of a video game to take control of an upcoming Iraq war title amid its ongoing dispute with the game's current developer, citing the risk of handing over the code without a trial.

  • August 17, 2026

    TikToker Sues PinkNews Over Unauthorized Snapchat Posts

    A skincare TikToker with nearly 1 million followers has sued an LGBTQ+ newspaper for copyright infringement, accusing the PinkNews media outlet of recording and publishing her content on Snapchat without her consent.

  • August 17, 2026

    Bacardi Beats Software Biz Over 'Martini' TM In EU

    Bacardi has persuaded European officials to block an Australian software company's trademark application for "Martini," demonstrating that consumers might confuse the sign with the spirits giant's signature vermouth brand.

  • August 17, 2026

    Meta Beats EUIPO Challenge To Infinity Logo

    European officials have refused to nix a Meta trademark with the infinity logo, as earlier rights over German company ThinkMeta Software's name didn't appear to have more than a "mere local significance." 

  • August 17, 2026

    Materials Biz Proves Manager Copied Docs For New Venture

    A London court held Monday that a former manager at a materials supplier breached his contract by copying almost 12,000 files he planned to use in a competing business.

  • August 17, 2026

    Acrisure Gets Order To Bar Former Execs Using Trade Secrets

    Acrisure secured a court order Monday barring its former CEO and CFO from using confidential information they had allegedly emailed themselves before joining rival insurance broker The Ardonagh Group.

  • August 17, 2026

    Formula One Loses Longstanding TM For Old 'F1' Logo

    Formula One has lost a longstanding European Union trademark for its former "F1" logo after another challenge from an individual who has repeatedly challenged the motorsport organization's brand protections within the bloc.

  • August 14, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen newly signed Real Madrid footballer Yan Diomandé sued over access to his image rights, Nigel Farage and Reform UK deputy leader Richard Tice accuse the NCA of leaking confidential financial information, and a right-wing American journalist hit The Guardian with a libel claim. 

  • August 14, 2026

    Temu Win Reinforces Protections For Online Retailers

    Temu's court win over Shein's copyright infringement claims made it clear that online marketplaces won't be liable for allegedly infringing images on their websites, unless they actively promote listings they believe are copycats, experts say.

  • August 14, 2026

    Swiss Drugmaker Extrovis Sues Ex-Partner For IP Portfolio

    Extrovis AG is suing its former joint venture partner to reclaim ownership of a patent portfolio covering medications which counter the effects of opioids and other products, alleging that its former partner wrongly claimed ownership rights in multiple jurisdictions.

  • August 14, 2026

    Photo Agency Says Staffer Sold Pics Without Permission

    A photography agency has accused a former employee of trying to sell pictures that he took while still on the company's books, telling a London court that the staffer infringed its copyright and breached his employment contract.

  • August 14, 2026

    Paddington Bear Brand Wins EU Battle To Block 'Paddi' Mark

    European officials have ruled in favor of the owner of the Paddington Bear brand and denied a Chinese company's trademark application for "Paddi," finding that it would be taking unfair advantage of the famous bear's reputation.

  • August 14, 2026

    Abbott Seeks UK Ban On Chinese Rival's Glucose Monitors

    Abbott has launched another case in England against medical device maker Sibionics, accusing the Chinese group of infringing its patent by selling rival glucose monitoring systems and escalating the companies' global patent fight.

Expert Analysis

  • Fed. Circ.'s Shaping Of Tech Patent Doctrine Resembles EPO's

    Author Photo

    The Federal Circuit's recent decision in Ceiva v. Amazon crystallizes an informal U.S. heuristic, "a technological solution to a technological problem," rewarding emphasis of a traceable chain from a problem to a solution — a lesson similar to the European Patent Office's "technical character" terminology, says Brandon Theiss at AddyHart.

  • Patent Dispute Takeaways From Ruling In Kodak Appeal

    Author Photo

    The Unified Patent Court’s recent appeal decision in Kodak v. Fujifilm, confirming that the UPC may exercise jurisdiction over non-UPC patent designations, creates opportunities for patentees to pursue claims involving both UPC and non-UPC designations before a single forum, say lawyers at Morgan Lewis.

  • Germany IP Rulings Clarify 'Willing' SEP Licensee Analysis

    Author Photo

    In light of a series of judgments from a German regional court and the Unified Patent Court, U.S. entities and their counsel should keep pace with the willing licensee standard developing abroad, as standard essential patent and fair, reasonable and nondiscriminatory licensing disputes have become cross-border campaigns, say attorneys at Fish & Richardson.

  • Who Owns The Data Behind The Beautiful Game?

    Author Photo

    Every match at the 2026 FIFA World Cup generates enormous volumes of information that can improve performance, enhance fan engagement and create new revenue streams, but that same data can also create significant legal exposure if rights and responsibilities are not clearly defined, say attorneys at Morgan Lewis.

  • Making Deals Once EU Merger, Investment Screenings Overlap

    Author Photo

    Though proposed updates would result in greater overlap between European Commission merger control efforts and foreign investment screening, dealmakers must understand how different objectives still drive these regimes and how this recalibrated regulatory environment will affect their transactions, say attorneys at Mayer Brown.

  • What EU Tech Licensing Changes Mean For Businesses

    Author Photo

    Following the European Union’s modernization of the Technology Transfer Block Exemption Regulation, organizations should consider how the broadened antitrust safe harbor applies, particularly where technology licensing agreements involve data-sharing arrangements, territorial restrictions or competitor relationships, say lawyers at Steptoe.

  • Coordinating Life Sciences IP Strategies In The US And EU

    Author Photo

    As postgrant practice for life sciences patents is restructured in the U.S. and European Union simultaneously, patent owners will need to implement transatlantic coordination that treats international proceedings as components of a single intellectual property risk architecture, says Paul Calvo at Sterne Kessler.

  • UK-Gulf Trade Deal Offers Key Benefits, But Hurdles Remain

    Author Photo

    The U.K.’s recent free trade agreement with the Gulf Cooperation Council is expected to deliver U.K. businesses a competitive advantage, with simplified procedures and tariff removal across manufacturing, services and digital trade sectors, but navigating Gulf regional tensions and differing regulatory regimes will create challenges, say lawyers at King & Spalding.

  • AI Makes Law Firm Change Management A Client Issue

    Author Photo

    As artificial intelligence implementation is causing clients' expectations of outside counsel to shift toward greater risk control and more transparent value, successful law firm transformation and the preservation of professional trust will require governance, training and accountability, says John Hutchinson at Broadfield.

  • Generic Drugs Do Not Reach Patients Sooner In The EU

    Author Photo

    Although the U.S. and European Union take very different approaches to patents, regulatory exclusivities and drug pricing, data shows that the effective market life for brand-name drugs is essentially the same in both jurisdictions, says Margaret Kyle at Mines Paris.

  • Guitar Shape Controversy Highlights Nuances Of IP Protection

    Author Photo

    A recent German case related to Fender's efforts to secure intellectual property protection for its Stratocaster guitar design highlights a structural tension inherent in IP law — the designs that most successfully become embedded in the cultural landscape are the hardest to justify exclusive ownership of, say attorneys at Spencer West.

  • AI Deals Call For Tailored Approach To Address Hidden Risks

    Author Photo

    As artificial intelligence deals continue to advance, they raise complex intellectual property questions with hard-to-verify technical facts that require a different approach to due diligence, risk allocation and execution, say lawyers at Katten.

  • Diverging Global AI Rules Raise IP Risks For UK Cos.

    Author Photo

    Several recent updates to U.K. intellectual property law as it relates to artificial intelligence mark a sharp divergence with approaches in the European Union and U.S., highlighting why a one-size-fits-all IP strategy is not viable for U.K. businesses operating across multiple jurisdictions, say lawyers at Skadden.

  • Series

    Studying Foreign Languages Makes Me A Better Lawyer

    Author Photo

    Studying Italian and Japanese has shown me that learning a new language can benefit a legal career in several ways, including by demonstrating the importance of approaching problems from a fresh perspective and the value of practicing patience with colleagues and clients, says Anna King at Genworth Financial.

  • 10 US Patent Pressure Points For EU Life Sciences Cos.

    Author Photo

    U.S.-specific patent issues can be challenging for European life sciences companies because they require decisions at the intersection of legal, scientific, regulatory and commercial functions, necessitating proactive, cross-functional steps from EU patent counsel, says Paul Calvo at Sterne Kessler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here